Traphagen Investment Advisors LLC Has $833,000 Position in The Procter & Gamble Company (NYSE:PG)

Traphagen Investment Advisors LLC boosted its stake in shares of The Procter & Gamble Company (NYSE:PGFree Report) by 2.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,969 shares of the company’s stock after acquiring an additional 105 shares during the quarter. Traphagen Investment Advisors LLC’s holdings in Procter & Gamble were worth $833,000 as of its most recent SEC filing.

Several other hedge funds have also recently bought and sold shares of the stock. Simon Quick Advisors LLC grew its holdings in shares of Procter & Gamble by 5.2% during the fourth quarter. Simon Quick Advisors LLC now owns 20,580 shares of the company’s stock worth $3,450,000 after purchasing an additional 1,015 shares during the last quarter. Beaumont Financial Advisors LLC grew its holdings in shares of Procter & Gamble by 1.0% during the fourth quarter. Beaumont Financial Advisors LLC now owns 19,509 shares of the company’s stock worth $3,271,000 after purchasing an additional 186 shares during the last quarter. Proquility Private Wealth Partners LLC grew its holdings in shares of Procter & Gamble by 1.1% during the fourth quarter. Proquility Private Wealth Partners LLC now owns 5,966 shares of the company’s stock worth $1,000,000 after purchasing an additional 66 shares during the last quarter. Verum Partners LLC grew its holdings in shares of Procter & Gamble by 1.9% during the fourth quarter. Verum Partners LLC now owns 6,446 shares of the company’s stock worth $1,081,000 after purchasing an additional 122 shares during the last quarter. Finally, Octavia Wealth Advisors LLC grew its holdings in shares of Procter & Gamble by 0.7% during the fourth quarter. Octavia Wealth Advisors LLC now owns 60,241 shares of the company’s stock worth $10,099,000 after purchasing an additional 405 shares during the last quarter. 65.77% of the stock is currently owned by institutional investors and hedge funds.

Procter & Gamble Stock Up 1.8 %

Shares of Procter & Gamble stock opened at $164.57 on Thursday. The business’s 50 day simple moving average is $169.01 and its 200 day simple moving average is $169.41. The Procter & Gamble Company has a 52-week low of $152.06 and a 52-week high of $180.43. The firm has a market cap of $387.56 billion, a PE ratio of 28.37, a P/E/G ratio of 3.63 and a beta of 0.45. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.55 and a current ratio of 0.75.

Procter & Gamble (NYSE:PGGet Free Report) last announced its earnings results on Wednesday, January 22nd. The company reported $1.88 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.86 by $0.02. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The business had revenue of $21.88 billion for the quarter, compared to analyst estimates of $21,657,595.49 billion. During the same quarter last year, the firm earned $1.84 EPS. Procter & Gamble’s revenue for the quarter was up 2.1% compared to the same quarter last year. On average, analysts predict that The Procter & Gamble Company will post 6.92 earnings per share for the current fiscal year.

Procter & Gamble Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, February 18th. Investors of record on Friday, January 24th will be given a $1.0065 dividend. This represents a $4.03 dividend on an annualized basis and a yield of 2.45%. The ex-dividend date of this dividend is Friday, January 24th. Procter & Gamble’s dividend payout ratio is presently 69.48%.

Insider Buying and Selling at Procter & Gamble

In other Procter & Gamble news, insider Balaji Purushothaman sold 12,800 shares of the firm’s stock in a transaction that occurred on Thursday, November 21st. The stock was sold at an average price of $172.73, for a total value of $2,210,944.00. Following the completion of the transaction, the insider now directly owns 11,595 shares in the company, valued at $2,002,804.35. This trade represents a 52.47 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Gary A. Coombe sold 47,847 shares of the firm’s stock in a transaction that occurred on Wednesday, November 27th. The shares were sold at an average price of $179.84, for a total value of $8,604,804.48. Following the completion of the transaction, the chief executive officer now owns 39,977 shares of the company’s stock, valued at approximately $7,189,463.68. This represents a 54.48 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 0.18% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on PG shares. Wells Fargo & Company decreased their price target on Procter & Gamble from $190.00 to $176.00 and set an “overweight” rating on the stock in a report on Tuesday, January 7th. Evercore ISI raised their price target on Procter & Gamble from $180.00 to $183.00 and gave the company an “outperform” rating in a report on Monday, October 21st. Royal Bank of Canada reiterated a “sector perform” rating and issued a $164.00 price target on shares of Procter & Gamble in a report on Monday, October 21st. Barclays decreased their price target on Procter & Gamble from $163.00 to $155.00 and set an “equal weight” rating on the stock in a report on Friday, January 17th. Finally, UBS Group decreased their price target on Procter & Gamble from $196.00 to $189.00 and set a “buy” rating on the stock in a report on Thursday, January 16th. Eight investment analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, Procter & Gamble presently has an average rating of “Moderate Buy” and an average target price of $179.65.

View Our Latest Research Report on Procter & Gamble

Procter & Gamble Profile

(Free Report)

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

Further Reading

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.